InflaRx NV buy Lifesci Capital
Start price
05.04.23
/
50%
€5.34
Target price
05.04.24
-
Performance (%)
-73.58%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. Massive losses of -73.58% were the result for the BUY prediction by Lifesci_Capital. Lifesci_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InflaRx NV | 16.891% | 16.891% | -70.797% |
| iShares Core DAX® | 1.851% | 5.158% | 17.711% |
| iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
| iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
| iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by Lifesci_Capital for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten